Skip to main content
. Author manuscript; available in PMC: 2017 Sep 4.
Published in final edited form as: Cancer Res. 2016 Nov 21;77(2):566–578. doi: 10.1158/0008-5472.CAN-16-1901

Figure 2.

Figure 2

Effect of drugs from panel A and panel B on the growth of TNBC cell lines. A: Percent growth inhibition of TNBC cell lines by single dose of each of the six panel A drugs (Cr=Crizotinib 1μM, Er=Erlotinib 3μM, Ev=Everolimus 30nM, Px=Paclitaxel 3nM, Vs=Vismodegib 10μM, XL=XL-184 3μM) from the medium-throughput drug screen. B: Growth inhibition by 128 panel B drugs as single treatments (2.4nM-10μM) in TNBC cell lines; vertical bars indicate the area under the individual dose response curve (AUC) for each drug.